MAP2 and neoplasm: As a proof of concept, we identified a therapeutic window for etoposide, a concentration range that maximized anti‐tumor efficacy while minimizing neuronal toxicity, by assessing its effects in both murine ETMR tumor (yellow fluorescent protein; YFP+) and neuronal (MAP2C+) FBO cells (Supplementary Figure S9).